Efficacy of quetiapine in treatment-resistant panic disorder: A case report

AbstractDepersonalization disorder is a poorly understood and treatment-resistant condition. This report describes a patient with depersonalization disorder who underwent six sessions of repetitive transcranial magnetic stimulation on the left dorsolateral prefrontal cortex. Repetitive transcranial magnetic stimulation produced a 28% reduction on depersonalization scores.

Download Full-text

Case report: successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

Psychopharmacology ◽

10.1007/s00213-003-1756-8 ◽

2004 ◽

Vol 173 (1-2) ◽

pp. 227-228 ◽

Cited By ~ 19

Author(s):

Jaskaran Singh ◽

Carlos A. Zarate ◽

Andrew D. Krystal

Keyword(s):

Case Report ◽

Bipolar Depression ◽

Augmentation Therapy ◽

Treatment Resistant

Download Full-text

Pindolol augmentation in treatment-resistant panic disorder and obsessive-compulsive disorder

European Neuropsychopharmacology ◽

10.1016/s0924-977x(98)80074-6 ◽

1998 ◽

Vol 8 ◽

pp. S99 ◽

Cited By ~ 3

Author(s):

J. Zohar ◽

P.N. Dannon ◽

Y. Sasson ◽

S. Hirschmann ◽

I. Iancu ◽

...

Keyword(s):

Panic Disorder ◽

Obsessive Compulsive Disorder ◽

Treatment Resistant ◽

Obsessive Compulsive ◽

Compulsive Disorder

Download Full-text

Coronavirus disease-19 Pandemic-Induced Panic Disorder

Open Access Macedonian Journal of Medical Sciences ◽

10.3889/oamjms.2021.6318 ◽

2021 ◽

Vol 9 (T3) ◽

pp. 237-239

Author(s):

Muhammad Surya Husada ◽

Mustafa M. Amin ◽

Munawir Saragih

Keyword(s):

Infectious Disease ◽

Case Report ◽

Panic Disorder ◽

Panic Attack ◽

Respiratory Symptoms ◽

Panic Attacks ◽

Psychosocial Burden ◽

Her Family ◽

Common Diagnosis ◽

The Individual

Background: COVID-19 is a newly emerging infectious disease which is found to be caused by SARS-2. COVID-19 pandemic has spread worldwide causing a rapidly increasing number of mental disorders cases, primarily anxiety disorder. Since majority of panic disorder patients are present with great anxiety in response to their physical or respiratory symptoms, support and encouragement from psychiatrist or therapist are fundamental to alleviate the severity of the symptoms. Case Report: We reported a case of COVID-19 induced panic disorder in a woman, 52 years old, batak tribe who started to experience multiple panic attacks since one of her family members was confirmed to be Covid-10 positive. Conclusion: In general, panic disorder is a common diagnosis, but this case appeared to be interesting as it is induced by COVID-19 pandemic. As in this case, the individual who experienced multiple panic attack is not even a COVID-19 patient but has one of her family member affected by the virus. A wide body of evidence has shown that this pandemic massively contributes to worsening of psychosocial burden in nationwide.

Download Full-text

Understanding Treatment-Resistant Depression: A Missionary’s Autobiographical Case Report

Christian Journal for Global Health ◽

10.15566/cjgh.v6i1.275 ◽

2019 ◽

Vol 6 (1) ◽

pp. 43-50

Author(s):

Hunter York

Keyword(s):

Case Report ◽

Depression Symptoms ◽

Primary Concern ◽

Treatment Resistant Depression ◽

Treatment Resistant ◽

Spiritual Discipline ◽

Convulsive Therapy ◽

Service Oriented ◽

Resistant Depression ◽

Electro Convulsive Therapy

As a career cross-cultural missionary in Southeast Asia, the author has seen first-hand and has personally experienced the devastating effects of colleagues, families, leaders, clinicians, and the sufferers themselves misunderstanding the symptoms and the reality of major depressive disorder, an increasing global health problem. This autobiographical case report reflects on twenty years of treatment-resistant depression and a journey through pharmacological approaches, psychotherapy treatment, Christian prayer counselling, and electro convulsive therapy without improvement in this condition. The primary concern is how to remain faithful and effective with this condition in a service-oriented occupation that requires regular emotional expenditure. In lieu of effective conventional and non-conventional therapies, the remaining option is to find a way to manage chronic depression; identify personal trends, weaknesses, and triggers; and find a personalized way to live that minimizes the effects of the condition. In any chronic, incurable disorder, the sufferer must inevitably come to terms with his or her reality and find peace in the acceptance of that reality. By expressing the journey through treatment-resistant depression, the author encourages readers to persevere in ministry and to respond more appropriately to the afflicted with clearer understanding and empathy. A companion article on mitigating depression symptoms through the spiritual discipline of identifying with Christ and His experience of human emotional pain during His passion is available.

Download Full-text

High-dose olanzapine in treatment resistant schizophrenia. A case report and literature review

BJPsych Open ◽

10.1192/bjo.2021.335 ◽

2021 ◽

Vol 7 (S1) ◽

pp. S115-S115

Author(s):

Ciara Clarke ◽

Clodagh Rushe ◽

Fintan Byrne

Keyword(s):

Case Report ◽

Literature Review ◽

The Body ◽

Psychotic Symptoms ◽

High Dose ◽

Extensive Literature ◽

Treatment Resistant ◽

Persecutory Delusions ◽

Full Resolution ◽

One Year

ObjectiveWe report a case of a 58-year-old gentleman who was hospitalised intermittently for one year due to treatment resistant schizophrenia. Prior to hospitalisation he had been prescribed standard antipsychotics for decades without full resolution of positive psychotic symptoms. During his final admission lasting six months he was guarded, suspicious, irritable, constantly paced the corridor and displayed thought block and paranoid persecutory delusions. He would not enter the assessment room or allow any blood or ECG monitoring, however, he was compliant with oral medication. He was successfully treated with high dose olanzapine (40mg/day) and was discharged to the community. The aim of this study is to bring awareness and add to the body of evidence for the use of high-dose olanzapine in patients with treatment resistant schizophrenia in whom a trial of clozapine is not possible.Case reportThe patient gave written consent for this case report to be written and presented. An extensive literature review was performed and key papers were identified. Discussion focuses on the key areas in the literature.DiscussionThis case demonstrates that high-dose olanzapine can be used effectively as an alternative to clozapine in treatment resistant schizophrenia.ConclusionThis case highlights the need for further evaluation of high-dose olanzapine as an alternative to clozapine in patients with treatment-resistant schizophrenia.

Download Full-text